Substance Abuse Deterrents and Treatments – An Assessment of the Technological, Competitive and R&D Landscape

US$ 2995

GBI Research’s latest report, “”Substance Abuse Deterrents and Treatments – An Assessment of the Technological, Competitive and R&D Landscape””, discusses global trends in the substance abuse deterrents and addiction treatments market including the impact substance abuse is having on local economies, healthcare systems and society as a whole.

04-26 2016   Pages: 73

Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies

US$ 2995

GBI Research’s latest report, “”Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies””, provides key insights into the global telehealth regulatory and market landscape, as well as its main applications in healthcare and associated sectors.

04-15 2016   Pages: 64

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

US$ 2995

GBI Research’s latest report, “”The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects”” discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status.

02-01 2016   Pages: 67

Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future

US$ 2995

GBI Research’s latest report, “”Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future”” discusses fundamental concepts in biobanking and recent technology advancements in the field.

01-12 2016   Pages: 118

Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity

US$ 2995

“Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity”” discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&A) and strategic alliances.

12-03 2015   Pages: 77

Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook

US$ 2995

Gene therapies have been in development in humans for 25 years, and a number of products have begun to enter the pharmaceutical market. However, due to various challenges and clinical trial setbacks, progress in developing this technology and achieving suitability for commercial usage has been slow.

10-12 2015   Pages: 43

Opioids Overview to 2021 – An Assessment of Pain Management and Dependence

US$ 2995

Analysis pertaining to the prescribed opioid users, treatment patterns, and market revenues confirms that the use of weak opioids has fallen dramatically in most markets, while the use of strong opioids has increased. The total market size in the countries covered in this report was $15.7 billion in 2014,

09-20 2015   Pages: 110

Life Cycle Management Strategies – Optimizing revenues and defending generic competition

US$ 2995

Life Cycle Management Strategies – Optimizing revenues and defending generic competition”” discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies,

08-16 2015   Pages: 100

C3 Jian, Inc – Product Pipeline Review – 2014

US$ 1500

– The report provides brief overview of C3 Jian, Inc including business description, key information and facts, and its locations and subsidiaries

08-02 2015   Pages: 29

Contract Research Organization Market – Global Deals and Operational Strategies

US$ 2995

“Contract Research Organization Market – Global Deals and Operational Strategies”” discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs.

07-06 2015   Pages: 77
Contact With Us
Join templatemonster at google+
Customized Research
Request Sample